Plain-English translation of NCT06845826 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
When you come to the emergency room with chest pain, doctors need to quickly figure out if you're having a heart attack. This trial is testing a new point-of-care troponin blood test — a faster version of the standard heart attack blood test that can give results right away in the emergency room instead of sending your blood to a lab. The goal is to see if this faster test helps doctors make treatment decisions more quickly and lets patients who don't have a heart attack go home sooner.
Right now, when someone comes to the ER with chest pain, their blood sample has to be sent to the hospital's central lab, which takes time. This trial exists because a faster test done right there in the emergency room could help doctors rule out heart attacks more quickly, reduce unnecessary waiting, and get patients with safe results discharged faster.
You likely qualify if…
You likely don't qualify if…
You will be randomly assigned to either the new rapid test group or the standard care group. Everyone first gets the usual emergency room care including a history, physical exam, and an ECG. If you're in the new test group, you'll have one extra small blood sample taken (just 30–100 microliters) so doctors can run the rapid troponin test right there in the ER; your sample will also go to the lab as a safety check. If you're in the standard group, you'll get the usual blood test sent to the lab. Your results will be available to guide the doctor's treatment decisions.
AI-generated summary from trial data · Jun 10, 2026 · Not medical advice
Belgium